Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novavax Inc (NVAX) vs Under Armour Inc Class A (UA) Price & Performance

Novavax IncTrade
Under Armour Inc Class ATrade

Price performance (Past 24H)

Key statistics

Novavax Inc vs Under Armour Inc Class A — how do they compare? Novavax Inc trades at $7.93 (market cap $1.31B), while Under Armour Inc Class A trades at $5.2 (market cap $2.26B). The key difference: Under Armour Inc Class A is the larger of the two by market cap. Which is the better fit depends on your goals.

NVAXUA
Market Cap
$1.31B$2.26B
Sector
HealthConsumer Cyclical
52-Week High
$11.19$7.88
52-Week Low
$6.22$3.96
Enterprise Value
$889.30M$3.24B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Novavax Inc

Novavax (NVAX) trades at $7.89, down 0.75% on the day, with a bullish technical signal despite mixed indicators. The company reported a strong Q2 2026 earnings beat, raising its full-year revenue outlook, while maintaining a low valuation with a P/E of 3.14 and EV/EBITDA of 1.72. However, negative net income margin and shareholder equity highlight financial challenges.

The outlook is cautiously optimistic, driven by partnership milestones with Sanofi and cost reductions, but risks include persistent cash burn and competitive vaccine market pressures. Analyst consensus leans bullish with 74% buy ratings, suggesting potential upside if execution improves.

Under Armour Inc Class A

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX

About Under Armour Inc Class A

Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.

Read more on UA